Hot Hands Bajaj Holdings & Investments, Max Healthcare Institute, and Dipak Nitrite can generate 16-21% returns in no time. this is why

In the post-December 2021 correction, the stock did not decline, indicating the growth of Bajaj Holdings and Investments. In recent weeks, the team has come out of a downward spiral, showing the beginning of a trend.

On monthly and even weekly charts, the Nifty remains on the upside, showing price weakness.

The price is trading above the 20-day SMA (simple moving average) every day, which supports price volatility.

Daily and weekly RSI (Relative Strength Index) above 50 indicates the strength of the index.

The indicator has placed immediate support at 17706 (20-day SMA) and 16380 (slope support). On the other hand, resistance is set at 18150 (high resistance) and 18350 (Jan 2022 high).

Looking at the overall shape of the chart, we believe that all trends are positive and the indicator may see a rise to the 18150 and 18350 levels. If we see the price holding below the 17.706 level, our opinion will be rejected.

Here are three recommendations to buy in the next 2-3 weeks:

Max Health Institute: From | LTP: Rs 439.55 | Stop Loss: Rs 406 | Target: $518 | Profit: 18%

If we look at the weekly period of Max Healthcare, we can see that the stock has increased significantly since November 2021. But after January 2022, the stock will be around Rs 350.

The commodity has seen two breakouts from lows in the past few weeks, indicating that the trend has started to change.

Bollinger Bands have started to rise daily, indicating a price reversal.

The RSI timeframe supports above 50 on the daily and weekly scales, indicating a strong rally.

Also, we expect the price to go up to the Rs 518 level, where the loss should be around Rs 406.

Nitrite Deepak: By | LTP: Rs 2,230.35 | Stop Loss: Rs 2045 | Target: Rs 2,600 | Profit: 16%

Nitrite Deepak: By | LTP: Rs 2,230.35 | Stop Loss: Rs 2045 | Target: Rs 2,600 | Profit: 16%

Looking at the big picture of Deepak Nitrite, the price showed a retracement from the 50 Fibonacci retracement level of Rs.311 (March 2020) to Rs.3020 (Oct 2021).

The product has been using a cup and handle system for a few weeks now, signaling the start of a reversal.

The breakout was confirmed by a high and range close to Rs 2,185 on the daily chart.

The price remained above the Bollinger Band on the daily chart, which indicates that the price is recovering.

The RSI on the daily time frame showed another reversal, indicating a break in the strong bullish pattern.

Looking back, we expect the price to move towards the Rs 2,600 level and stop losses at Rs 2,045 based on the closing price.

Bajaj Holding and Investment: Buy | LTP: $7,110.60 | Stop Loss: Rs 6400 | Target: £8,610 | Revenue: 21%

Bajaj Holding and Investment: Buy | LTP: $7,110.60 | Stop Loss: Rs 6400 | Target: £8,610 | Revenue: 21%

We see that the general price trend is rising every day. The stock has crossed its post-December 2021 correction lows and highs, indicating a bullish tone for the stock.

The stock broke out of last week’s cycle pattern, signaling the start of an uptrend.

This development is confirmed by the large volume.

The daily Bollinger Bands time horizon has begun to widen, indicating greater price volatility for an upward move.

The daily and weekly RSI remain above 50, indicating strong price action.

Find out more about BOLSA DE VALORES has recorded a return of more than 12,000% in 10 years.

Recovery of more than 12000% in 10 years! Are you so cold?

The shares rose 2.56% to Rs 1,918.65 from the previous close of Rs 1,969.15 amid weak market trading. The company’s market share fell to Rs 26,169.05.

Over 500% of Deepak Nitrite shares were returned to shareholders within three years. Additionally, long-term investors have received a high return by investing in this fund, as it has grown over 12,000% over the past 10 years.

The shares rose 2.56% to Rs 1,918.65 from the previous close of Rs 1,969.15 amid weak market trading. The company’s market share fell to Rs 26,169.05.

In March 2022, the company made a profit of Rs 267 crore or 7.89% from Rs. Rs 290 crore in March 2021. Net sales were Rs 1,872 crore in March 2022, 27.96% more than Rs 1.1 crore vs. Rs 290 crore in March.

“Shares are trading at 26x/24x earnings per share for FY23/24/FY24. Prices remain volatile, and the scope for earnings growth is limited until green development expansion is introduced (low yield in phenol, phenol consumption margin 35-40%. We believe the stock has a 26x multiplier). According to Matilal Oswal, the EPS for FY24 was Rs 2,320 crore.

Dolat Capital believes that the presence of underwater resources and advanced chemical processes will reduce industry volatility while ensuring high FCFF and ROE.

“We maintain a forward sell estimate of Rs 2,881 per share (30x 24FY24E),” the broker said.

Notably, in March, Indian Life Insurance Corporation (LIC) went public on Dalal Road and increased its stake in Deepak Nitrite.

Deepak Nitrite is a chemical company. The Company’s divisions include Basic Chemicals, Fine and Specialty Chemicals, Functional Products, and Phenolic Resins.

Max Healthcare plans to invest INR 160 crore to add around 1,000 beds to Gurugram.

With the addition of two facilities in Gurugram with roughly 500 beds each, the company will “strengthen its position in NCR and extend its bed capacity,” according to Max Healthcare.

Max Healthcare on Tuesday said he plans to invest Rs 160 crore to increase facilities in the metropolitan area by adding about 1,000 beds in Gurugram, Haryana.

In a regulatory filing, Max Healthcare said it would “further increase its presence in NCR and expand its bed capacity by adding two more hospitals to his Gurugram, which has approximately 500 beds.” I’m here.

The total investment is expected to be around Rs 160 billion. It is proposed to fund the expansion plan through internal expenses, loans, and/or other means authorized by applicable law,” Max Healthcare Institute said.

For the two hospitals, the company has allotted his two lands of about 6.11 and 5.26 acres after winning his recent HUDA auction, the company said.

Abhay Soi, President, and CEO of Max Healthcare said:

Max Healthcare now runs a referral hospital in Gurugram, he said.

Max Healthcare Institute’s shares closed at Rs 352.95 per bar on the BSE, down 1.63% from the previous close.

Max Healthcare is one of the largest private sector healthcare facility networks with a majority of 17 healthcare facilities in North India.

Eight hospitals and four clinics in the network are located in Delhi and his NCR, and the rest are in Mumbai, Mohali, Bathinda, and Dehradun.

Leave a Comment